The 32nd annual meeting of the European Association for the Study of Diabetes. Leptin, insulin resistance, intrauterine malnutrition, sulfonylureas, oral agents alone and with insulin, and new pharmacological approaches to type 2 diabetes.
Bloomgarden
Z T
ZT
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D015415:Biomarkers / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D005060:Europe; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D007333:Insulin Resistance; D020738:Leptin; D009748:Nutrition Disorders / Q000150:complications*; D011506:Proteins / Q000378:metabolism; D012955:Societies, Medical; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D015415:Biomarkers; D007004:Hypoglycemic Agents; D007328:Insulin; D020738:Leptin; D011506:Proteins; D013453:Sulfonylurea Compounds